Repligen

US · RGEN #1445 by market cap Listed 1970

167.22 -7.64 -4.37%

Live - 5344 symbols - heartbeat 306s ago · 2026-10-08 05:35

Pre-market 165.14 -1.24%

After-hours 167.22 0.00%

Overnight 166.83 -0.23%

Market cap: 10.62B
P/E (TTM): 229.07
P/B: 5.03
EPS: 0.86
Div yield: 0.00%
52W pos: 68%

Reader sentiment Are you bullish or bearish on RGEN?

Anonymous reader poll. Unscientific, not investment advice.

About Repligen

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Founded: 1981
CEO: Mr. Olivier Loeillot
Employees: 2,000
Headquarters: Waltham, Massachusetts, United States of America
Fiscal year end: 12-31
Website: repligen.com

Company profile

Exchange: US
Symbol: RGEN
Market-cap rank: #1445
Listing date: 1970-01-01
Market cap: 10.62B
Float cap: 10.12B
Shares out: 63.49M
Float shares: 60.53M

Sectors & themes

Medical Instruments & Supplies Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 05:35:55 · For reference only, not investment advice and not tailored to your situation.